Global Injectable Drug Delivery Formulation Market Status and Outlook 2018-2025

August 2018 | 115 pages | ID: GFA18B4A65DEN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Becton, Dickinson and Company (U.S.)
• Baxter International Inc. (U.S.)
• Gerresheimer AG (Germany)
• Pfizer, Inc. (U.S.)
• Schott AG (Germany)
• Sandoz (Germany)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Eli Lilly and Company (U.S.)

Market by Type

• Conventional Drug Delivery Formulations
• Novel Drug Delivery Formulations
• Long-acting Formulations

Market by Application

• Autoimmune Diseases
• Hormonal Disorders
• Oncology
• Orphan Diseases
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Injectable Drug Delivery Formulation Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Conventional Drug Delivery Formulations
  3.1.2 Novel Drug Delivery Formulations
  3.1.3 Long-acting Formulations
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Autoimmune Diseases
  4.1.2 Hormonal Disorders
  4.1.3 Oncology
  4.1.4 Orphan Diseases
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Conventional Drug Delivery Formulations Production by Region
    6.1.1.2 Novel Drug Delivery Formulations Production by Region
    6.1.1.3 Long-acting Formulations Production by Region
  6.1.2 Production by Application
    6.1.2.1 Autoimmune Diseases Production by Region
    6.1.2.2 Hormonal Disorders Production by Region
    6.1.2.3 Oncology Production by Region
    6.1.2.4 Orphan Diseases Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Conventional Drug Delivery Formulations Demand by Region
    6.2.1.2 Novel Drug Delivery Formulations Demand by Region
    6.2.1.3 Long-acting Formulations Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Autoimmune Diseases Demand by Region
    6.2.2.2 Hormonal Disorders Demand by Region
    6.2.2.3 Oncology Demand by Region
    6.2.2.4 Orphan Diseases Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Becton, Dickinson and Company (U.S.)
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Baxter International Inc. (U.S.)
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Gerresheimer AG (Germany)
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Pfizer, Inc. (U.S.)
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Schott AG (Germany)
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Sandoz (Germany)
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Teva Pharmaceutical Industries Ltd. (Israel)
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Eli Lilly and Company (U.S.)
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Injectable Drug Delivery Formulation Industry Dynamics & Regulations List
Table Global Injectable Drug Delivery Formulation Sales Revenue, Cost and Margin, 2015-2018E
Table Global Injectable Drug Delivery Formulation Market Status by Type 2015-2018E, in USD Million
Table Global Injectable Drug Delivery Formulation Market Status by Application 2015-2018E, in USD Million
Table Global Injectable Drug Delivery Formulation Market Status by Application 2015-2018E, in Volume
Table Global Injectable Drug Delivery Formulation Market by Region 2015-2018E, in USD Million
Table Global Injectable Drug Delivery Formulation Market Share by Region in 2018, in USD Million
Table Global Injectable Drug Delivery Formulation Market by Region 2015-2018E, in Volume
Table Global Injectable Drug Delivery Formulation Market Share by Region in 2018, in Volume
Table Conventional Drug Delivery Formulations Production Value by Region 2015-2018E, in USD Million
Table Conventional Drug Delivery Formulations Production Volume by Region 2015-2018E, in Volume
Table Novel Drug Delivery Formulations Production Value by Region 2015-2018E, in USD Million
Table Novel Drug Delivery Formulations Production Volume by Region 2015-2018E, in Volume
Table Long-acting Formulations Production Value by Region 2015-2018E, in USD Million
Table Long-acting Formulations Production Volume by Region 2015-2018E, in Volume
Table Autoimmune Diseases Production Value by Region 2015-2018E, in USD Million
Table Autoimmune Diseases Production Volume by Region 2015-2018E, in Volume
Table Hormonal Disorders Production Value by Region 2015-2018E, in USD Million
Table Hormonal Disorders Production Volume by Region 2015-2018E, in Volume
Table Oncology Production Value by Region 2015-2018E, in USD Million
Table Oncology Production Volume by Region 2015-2018E, in Volume
Table Orphan Diseases Production Value by Region 2015-2018E, in USD Million
Table Orphan Diseases Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Conventional Drug Delivery Formulations Market Size by Region 2015-2018E, in USD Million
Table Conventional Drug Delivery Formulations Market Size by Region 2015-2018E, in Volume
Table Novel Drug Delivery Formulations Market Size by Region 2015-2018E, in USD Million
Table Novel Drug Delivery Formulations Market Size by Region 2015-2018E, in Volume
Table Long-acting Formulations Market Size by Region 2015-2018E, in USD Million
Table Long-acting Formulations Market Size by Region 2015-2018E, in Volume
Table Autoimmune Diseases Market Size by Region 2015-2018E, in USD Million
Table Autoimmune Diseases Market Size by Region 2015-2018E, in Volume
Table Hormonal Disorders Market Size by Region 2015-2018E, in USD Million
Table Hormonal Disorders Market Size by Region 2015-2018E, in Volume
Table Oncology Market Size by Region 2015-2018E, in USD Million
Table Oncology Market Size by Region 2015-2018E, in Volume
Table Orphan Diseases Market Size by Region 2015-2018E, in USD Million
Table Orphan Diseases Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalInjectable Drug Delivery Formulation Forecast by Type 2019F-2025F, in USD Million
Table Injectable Drug Delivery Formulation Forecast by Type 2019F-2025F, in Volume
Table Injectable Drug Delivery Formulation Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Injectable Drug Delivery Formulation Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Injectable Drug Delivery Formulation Market Forecast by Region 2019F-2025F, in USD Million
Table Injectable Drug Delivery Formulation Market Forecast by Region 2019F-2025F, in Volume
Table Becton, Dickinson and Company (U.S.) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Becton, Dickinson and Company (U.S.)
Table Baxter International Inc. (U.S.) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Baxter International Inc. (U.S.)
Table Gerresheimer AG (Germany) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Gerresheimer AG (Germany)
Table Pfizer, Inc. (U.S.) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Pfizer, Inc. (U.S.)
Table Schott AG (Germany) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Schott AG (Germany)
Table Sandoz (Germany) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Sandoz (Germany)
Table Teva Pharmaceutical Industries Ltd. (Israel) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Teva Pharmaceutical Industries Ltd. (Israel)
Table Eli Lilly and Company (U.S.) Information
Table Injectable Drug Delivery Formulation Sales, Cost, Margin of Eli Lilly and Company (U.S.)
Table Global Injectable Drug Delivery Formulation Sales Revenue by Company 2015-2017, in USD Million
Table Global Injectable Drug Delivery Formulation Sales Volume by Company 2015-2017, in Volume
Table Global Injectable Drug Delivery Formulation Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Injectable Drug Delivery Formulation Picture
Figure Injectable Drug Delivery Formulation Industry Chain Diagram
Figure Global Injectable Drug Delivery Formulation Sales Revenue 2015-2018E, in USD Million
Figure Global Injectable Drug Delivery Formulation Sales Volume 2015-2018E, in Volume
Figure Global Injectable Drug Delivery Formulation Market Status by Type 2015-2018E, in Volume
Figure North America Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in USD Million
Figure North America Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in Volume
Figure Europe Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in USD Million
Figure Europe Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in Volume
Figure South America Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in USD Million
Figure South America Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in Volume
Figure Middle East Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in Volume
Figure Africa Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in USD Million
Figure Africa Injectable Drug Delivery Formulation Market Size and Growth 2015-2018E, in Volume
Figure Global Injectable Drug Delivery Formulation Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Injectable Drug Delivery Formulation Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Injectable Drug Delivery Formulation Sales Price Forecast 2019F-2025F
Figure Global Injectable Drug Delivery Formulation Gross Margin Forecast 2019F-2025F
Figure Global Injectable Drug Delivery Formulation Sales Revenue by Company in 2018, in USD Million
Figure Global Injectable Drug Delivery Formulation Price by Company in 2018
Figure Global Injectable Drug Delivery Formulation Gross Margin by Company in 2018